行為復健市場－全球產業規模、佔有率、趨勢、機會和預測，按行為障礙類型、醫療環境、治療方法、地區和競爭細分，2020 年至 2030 年

2024年，全球行為復健市場規模達2,254.2億美元，預計在預測期內將顯著成長，到2030年複合年成長率將達到6.07%。行為復健是一種心理治療技術，用於解決對個人健康構成威脅的特定習得行為。此方法涵蓋諮商、藥物治療以及一系列支援服務，包括強化、懲罰和榜樣示範。其目的是改變個人的心理狀態，減少自我毀滅和不健康行為的發生。透過辨識和解決與易怒、不當行為、藥物濫用、憂鬱、焦慮、衝動、攻擊性、過動和悲傷相關的模式，行為復健為個人提供有效的策略來管理自己的情緒和行為，治療人格、情緒和注意力不足過動症。行為復健涉及後天性腦損傷的後期治療，特別著重於應對患者情緒狀態的變化。這種治療形式可以幫助患者獲得有效管理不當行為的技能，這些行為可能會對家人、同事、朋友和其他人造成困擾。行為復健可以有效解決諸如易怒、情緒波動、情緒不穩定以及參與不當行為等症狀。

關鍵市場促進因素

精神健康障礙盛行率上升

主要市場挑戰

缺乏患者登記

主要市場趨勢

越來越多的數位戒毒項目

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球行為復健市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依行為障礙類型（焦慮症、情緒障礙、物質濫用障礙、人格障礙和注意力缺陷障礙）
  • 依醫療環境（門診行為復健、住院行為復健和住宅行為復健）
  • 依治療方法（諮詢、藥物、支持服務和其他治療方法）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美行為復健市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲行為復健市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太行為康復市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲行為復健市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲行為復健市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Allergan, Inc.
• Novartis AG
• Taro Pharmaceutical Industries
• Perrigo Company plc
• Zynerba Pharmaceuticals
• Apotex Inc.
• Sandoz AG
• Strides Arcolab Ltd.
• TOLMAR Pharmaceuticals, Inc.
• Limbix Health Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

Global Behavioural Rehabilitation Market was valued at USD 225.42 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.07% through 2030. Behavioral rehabilitation is a psychotherapeutic technique employed to address specific learned behaviors that pose a threat to an individual's well-being. This approach encompasses counseling, medication, and a range of support services, including reinforcement, punishment, and modeling. Its aim is to modify an individual's psychological conditioning, reducing the occurrence of self-destructive and unhealthy behaviors. By identifying and addressing patterns associated with irritability, inappropriate actions, substance abuse, depression, anxiety, impulsivity, aggression, hyperactivity, and grief, behavioral rehabilitation equips individuals with effective strategies to manage their emotions and actions, treating personality, mood, and attention deficit disorders. Behavioral rehabilitation pertains to the post-treatment of acquired brain injuries, with a specific focus on addressing changes in the patient's emotional state. This form of treatment aids patients in acquiring skills to effectively manage inappropriate actions that may pose challenges to their family members, co-workers, friends, and others. Symptomatic manifestations such as increased irritability, mood swings, emotional lability, and engaging in inappropriate behaviors are among the issues that can be effectively addressed through behavioral rehabilitation.

Key Market Drivers

Increase in the Prevalence of Mental Health Disorders

The rise in the prevalence of mental health disorders worldwide serves as a significant driver for the growth of the behavioral rehabilitation market. For instance, according to the NIH, over one in five U.S. adults-approximately 59.3 million people or 23.1% of the adult population-were living with a mental illness in 2022. This statistic highlights the widespread impact of mental health conditions across the country and underscores the urgent need for accessible, effective mental health services and support systems to address the growing demand for care. The emergence of various internet interventions for treating common mental disorders, particularly in remote patient monitoring and easy accessibility, along with the widespread adoption of cost-effective online counseling sessions, contribute to the accelerated market growth. For instance, in September 2023, Praesum Healthcare Services, LLC acquired Beacon Point Recovery Center, LLC, a behavioral health provider network based in Philadelphia, U.S. The acquisition aims to expand Praesum's footprint in the behavioral health sector and enhance access to quality mental health and addiction treatment services in the region. The increasing prevalence of anxiety, dementia, depression, and other psychological disorders among the population is a key driver for market growth. The growing preference for partial hospitalization programs (PHPs) among patients is bolstering market expansion. These multi-day programs, offered by rehabilitation centers and hospitals, aim to facilitate emotional regulation, conflict resolution, anger management, and substance abuse treatment. In line with this, various government and non-government organizations also organize camps to provide behavioral rehabilitation for individuals with post-traumatic stress disorder (PTSD) and drug addiction, thereby contributing to market growth. The availability of online counseling services acts as another growth-inducing factor. With the onset of the Covid-19 pandemic, individuals are increasingly adopting online platforms to access timely treatment and recovery support.

Key Market Challenges

Lack of Patient Enrollment

The lack of patient enrollment hinders the growth of behavioral rehabilitation programs. Patient enrollment refers to the process of recruiting and enrolling individuals into these programs for treatment and intervention. This challenge can impact the effectiveness, reach, and sustainability of behavioral rehabilitation efforts. Low patient enrollment can result in a limited number of individuals accessing behavioral rehabilitation services. This restricts the availability of treatment options for those in need and can contribute to unmet mental health and behavioral health needs. Behavioral rehabilitation programs often require significant resources, including trained professionals, facilities, and support staff. A lack of patient enrollment means that these resources might be underutilized, leading to inefficiencies and decreased cost-effectiveness. Many behavioral rehabilitation programs rely on patient fees, insurance reimbursements, or government funding to operate. A lack of patient enrollment can strain the financial sustainability of programs, potentially leading to reduced services or closure.

Key Market Trends

Increasing Number of Digital Detoxification Programs

The growing prevalence of digital detoxification programs is a significant driver of market growth in the behavioral rehabilitation sector. Internet and social media addictions have seen a surge due to global technological advancements, impacting individuals, particularly teenagers and young adults who are tech-savvy. Digital detox programs play a crucial role in addressing internet addiction, with the Chinese government taking the lead in implementing boot camps specifically targeting young adults. The focus on digital detoxification programs in Asia is expected to prompt other countries worldwide to follow suit, resulting in an increased number of digital rehabilitation programs and driving market growth throughout the forecast period.

Key Market Players

Allergan, Inc.

Novartis AG

Taro Pharmaceutical Industries

Perrigo Company plc

Zynerba Pharmaceuticals

Apotex Inc.

Sandoz AG

Strides Arcolab Ltd.

TOLMAR Pharmaceuticals, Inc.

Limbix Health Inc

Report Scope:

In this report, the Global Behavioural Rehabilitation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Behavioural Rehabilitation Market, By Type of Behavioural Disorder:

• Anxiety Disorder
• Mood Disorder
• Substance Abuse Disorder
• Personality Disorder
• Attention Deficit Disorder

Behavioural Rehabilitation Market, By Healthcare Setting:

• Outpatient Behavioural Rehabilitation
• Inpatient Behavioural Rehabilitation
• Residential Behavioural Rehabilitation

Behavioural Rehabilitation Market, By Treatment Method:

• Counselling
• Medication
• Support Services
• Other Treatment Methods

Behavioural Rehabilitation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Behavioural Rehabilitation Market.

Available Customizations:

Global Behavioural Rehabilitation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Behavioural Rehabilitation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Behavioural Disorder (Anxiety Disorder, Mood Disorder, Substance Abuse Disorder, Personality Disorder, and Attention Deficit Disorder)
  • 5.2.2. By Healthcare Setting (Outpatient Behavioural Rehabilitation, Inpatient Behavioural Rehabilitation, and Residential Behavioural Rehabilitation)
  • 5.2.3. By Treatment Method (Counselling, Medication, Support Services, and Other Treatment Methods)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Behavioural Rehabilitation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Behavioural Disorder
  • 6.2.2. By Healthcare Setting
  • 6.2.3. By Treatment Method
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Behavioural Rehabilitation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Behavioural Disorder
      • 6.3.1.2.2. By Healthcare Setting
      • 6.3.1.2.3. By Treatment Method
  • 6.3.2. Canada Behavioural Rehabilitation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Behavioural Disorder
      • 6.3.2.2.2. By Healthcare Setting
      • 6.3.2.2.3. By Treatment Method
  • 6.3.3. Mexico Behavioural Rehabilitation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Behavioural Disorder
      • 6.3.3.2.2. By Healthcare Setting
      • 6.3.3.2.3. By Treatment Method

7. Europe Behavioural Rehabilitation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Behavioural Disorder
  • 7.2.2. By Healthcare Setting
  • 7.2.3. By Treatment Method
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Behavioural Rehabilitation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Behavioural Disorder
      • 7.3.1.2.2. By Healthcare Setting
      • 7.3.1.2.3. By Treatment Method
  • 7.3.2. United Kingdom Behavioural Rehabilitation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Behavioural Disorder
      • 7.3.2.2.2. By Healthcare Setting
      • 7.3.2.2.3. By Treatment Method
  • 7.3.3. Italy Behavioural Rehabilitation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Behavioural Disorder
      • 7.3.3.2.2. By Healthcare Setting
      • 7.3.3.2.3. By Treatment Method
  • 7.3.4. France Behavioural Rehabilitation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Behavioural Disorder
      • 7.3.4.2.2. By Healthcare Setting
      • 7.3.4.2.3. By Treatment Method
  • 7.3.5. Spain Behavioural Rehabilitation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Behavioural Disorder
      • 7.3.5.2.2. By Healthcare Setting
      • 7.3.5.2.3. By Treatment Method

8. Asia-Pacific Behavioural Rehabilitation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Behavioural Disorder
  • 8.2.2. By Healthcare Setting
  • 8.2.3. By Treatment Method
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Behavioural Rehabilitation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Behavioural Disorder
      • 8.3.1.2.2. By Healthcare Setting
      • 8.3.1.2.3. By Treatment Method
  • 8.3.2. India Behavioural Rehabilitation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Behavioural Disorder
      • 8.3.2.2.2. By Healthcare Setting
      • 8.3.2.2.3. By Treatment Method
  • 8.3.3. Japan Behavioural Rehabilitation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Behavioural Disorder
      • 8.3.3.2.2. By Healthcare Setting
      • 8.3.3.2.3. By Treatment Method
  • 8.3.4. South Korea Behavioural Rehabilitation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Behavioural Disorder
      • 8.3.4.2.2. By Healthcare Setting
      • 8.3.4.2.3. By Treatment Method
  • 8.3.5. Australia Behavioural Rehabilitation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Behavioural Disorder
      • 8.3.5.2.2. By Healthcare Setting
      • 8.3.5.2.3. By Treatment Method

9. South America Behavioural Rehabilitation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Behavioural Disorder
  • 9.2.2. By Healthcare Setting
  • 9.2.3. By Treatment Method
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Behavioural Rehabilitation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Behavioural Disorder
      • 9.3.1.2.2. By Healthcare Setting
      • 9.3.1.2.3. By Treatment Method
  • 9.3.2. Argentina Behavioural Rehabilitation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Behavioural Disorder
      • 9.3.2.2.2. By Healthcare Setting
      • 9.3.2.2.3. By Treatment Method
  • 9.3.3. Colombia Behavioural Rehabilitation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Behavioural Disorder
      • 9.3.3.2.2. By Healthcare Setting
      • 9.3.3.2.3. By Treatment Method

10. Middle East and Africa Behavioural Rehabilitation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Behavioural Disorder
  • 10.2.2. By Healthcare Setting
  • 10.2.3. By Treatment Method
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Behavioural Rehabilitation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Behavioural Disorder
      • 10.3.1.2.2. By Healthcare Setting
      • 10.3.1.2.3. By Treatment Method
  • 10.3.2. Saudi Arabia Behavioural Rehabilitation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Behavioural Disorder
      • 10.3.2.2.2. By Healthcare Setting
      • 10.3.2.2.3. By Treatment Method
  • 10.3.3. UAE Behavioural Rehabilitation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Behavioural Disorder
      • 10.3.3.2.2. By Healthcare Setting
      • 10.3.3.2.3. By Treatment Method

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Allergan, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Novartis AG
• 14.3. Taro Pharmaceutical Industries
• 14.4. Perrigo Company plc
• 14.5. Zynerba Pharmaceuticals
• 14.6. Apotex Inc.
• 14.7. Sandoz AG
• 14.8. Strides Arcolab Ltd.
• 14.9. TOLMAR Pharmaceuticals, Inc.
• 14.10. Limbix Health Inc.

15. Strategic Recommendations

16. About Us & Disclaimer